• info@eappsys.com
Free Consultation

Cloud Platform Application Development with AI to Extend Fusion SaaS

Cloud Platform Application Development with AI to Extend Fusion SaaS

Client Overview:

Clinigen Group is a global pharmaceutical and services company, specializing in providing ethical access to critical medicines. With a complex supply chain, regulatory compliance demands, and a hybrid ERP landscape combining Oracle E-Business Suite (eBS) along with various custom solutions, Clinigen sought to modernize its infrastructure and improve database performance to meet evolving business needs.

Business Challenge:

Clinigen Group, a global pharmaceutical and services company, specializes in providing ethical access to critical medicines. With a complex supply chain, regulatory compliance demands, and a hybrid ERP landscape combining Oracle Fusion Cloud with Oracle E-Business Suite (eBS), Clinigen required a modernized and intelligent solution to optimize operations and deliver better outcomes for healthcare providers and patients worldwide.

Manual Compliance and Regulatory Tracking: Navigating a global compliance landscape meant manual processes for monitoring regulatory changes, increasing the risk of errors and delays.
Disconnected Systems for Pharmacovigilance and Supply Chain: Integration gaps between Fusion Cloud and legacy eBS systems caused delays in mission-critical decision-making.
Inefficient Demand Forecasting: Traditional models failed to predict spikes in demand for rare and unlicensed medicines, often leading to overstocking or shortages.
Data Silos Limiting Insights: The inability to consolidate insights across systems limited the strategic use of operational and customer data, leading to reactive, rather than proactive, decision-making.

Solution Provided by eAppSys:

eAppSys delivered a cutting-edge Cloud Platform Application Development solution, powered by Oracle Cloud Infrastructure (OCI) and AI/ML capabilities, to seamlessly extend Fusion SaaS and eBS. The solution included:

AI-Driven Demand Forecasting: Leveraging OCI Data Science and pre-trained ML models, Clinigen was equipped with AI tools that analyze historical sales, real-time order trends, and external variables (e.g., disease outbreaks) to predict medicine demand with high accuracy.
Oracle Integration Cloud (OIC): OIC was used to bridge data between Oracle Fusion, eBS, and third-party regulatory databases. This enabled a unified view of operations, facilitating automated regulatory updates and real-time alerting for compliance risks.
Oracle APEX (Application Express): Clinigen’s business users were empowered with low-code dashboards to track regulatory changes, forecast inventory needs, and assess market dynamics—all without IT intervention.

Technologies Leveraged:

OCI Data Science & AI Services: For predictive forecasting and AI-based regulatory tracking.
Oracle Integration Cloud (OIC): To unify Fusion Cloud, eBS, and external systems.
Oracle APEX: For custom dashboards, business user analytics, and monitoring tools.

Business Impact:

Proactive Inventory Management: AI models reduced medicine stockouts by 35% and optimized inventory holding costs across multiple geographies.
Streamlined Compliance: Automated monitoring of regulatory changes decreased manual effort by 50%, reducing risk and improving audit readiness.
Improved Operational Intelligence: Real-time dashboards and smart assistants enabled data-driven decisions across supply chain, pharmacovigilance, and finance.
Unified Ecosystem Efficiency: The integration between Fusion Cloud, eBS, and third-party data sources allowed processes to flow seamlessly, eliminating operational silos.
Strengthened Security Posture: Oracle’s layered security tools ensured that Clinigen met global data protection and regulatory requirements.

Conclusion:

eAppSys’s strategic partnership with Clinigen resulted in a powerful blend of AI, integration, and user-focused application development within the Oracle Cloud Infrastructure ecosystem. The extended solution not only addressed Clinigen’s immediate regulatory and operational challenges but also laid a scalable and intelligent foundation to support their future growth—enabling faster, smarter, and more secure delivery of life-saving medicines across the globe.